Peptide Therapeutics
Peptide therapeutics under the post-reclassification regulatory landscape. Eight hours, fifteen lessons.
Free with active GentsMed Network membership ($99/mo), or included in the $1,497 one-time Provider Certification purchase. Lifetime access.
What you'll learn
- Peptide regulatory landscape post-April 2026 reclassification
- July 2026 PCAC determinations and what they changed
- Sermorelin, BPC-157, TB-500, CJC-1295 / Ipamorelin: clinical use cases
- Compounding pharmacy partnerships vs gray-market exposure
- Patient consent, monitoring, and documentation
Topics covered: Regulatory framework, April 2026 reclassification, July 2026 PCAC, gray-market exposure.
Who this module is for
Providers prescribing peptides in 2026 — covering the post-reclassification regulatory landscape and the gray-market exposure that's putting clinics at risk.
Plus everything in the GentsMed Network
Active network members also get:
- National directory listing on gentsmed.com
- AI SMS bot + voice agent for after-hours patient comms
- Patient leads forwarded to your office
- Marketing co-op + national PR amplification
- 20–25% discount on every procedural course
- The “GentsMed Certified — Active Network Member” badge
Other modules in the curriculum
Continue with another module.
- Module 1
Foundations of Practice
Intake, labs, off-label / consent, scope, compounding primer, documentation.
9 hrs · 15 lessonsFree with cert → - Module 2
Testosterone Therapy
Cypionate, Kyzatrex, hCG, SERMs, AIs, monitoring, TRAVERSE.
10 hrs · 18 lessonsFree with cert → - Module 3
Sexual Wellness Pharmacotherapy
PDE5i (all 4), Princeton IV, bremelanotide, escalation pathway.
9 hrs · 16 lessonsFree with cert →
Ready to add this to your practice?
Short application — under two minutes. We'll verify your license and NPI and send next steps.